Company / Gross Profit
60 DEGREES PHARMACEUTICALS, INC. Gross Profit History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$222.8K
FY2025
5-year range
-$221.0K / $222.8K
FY2023-FY2025
Trend
+200.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit changed +201% YoY in FY2025, a notable deviation from the 2-year average annual change of +98%.
Based on SEC 10-K filings.
$222,809 in FY2025.
Improved from -$209,162 to $222,809 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit increased 200.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $222.8K | +200.8% |
| FY2024 | -$221.0K | -5.6% |
| FY2023 | -$209.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026